š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The primary objective of this study is the estimation of the human papillom...
Status
Completed
Location
Sotobo Children's Clinic ( Site 6616)
Start Date
2021-05-17
Trial ID
NCT04772534
Treatments Being Tested
A randomized, observer-blind non-inferiority trial to evaluate alternative ...
Status
Unknown
Location
Ed Clarke
Start Date
2019-09-14
Trial ID
NCT03832049
The main purpose of this study was to evaluate the safety and reactogenicit...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-08-22
Trial ID
NCT05496231
Treatments Being Tested
This phase II trial studies whether the nonavalent human papillomavirus vac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-06-23
Trial ID
NCT03036930
Primary objective: ā¢ To demonstrate that administration of V503 induces no...
Status
Completed
Location
Multiple Locations
Start Date
2011-02-23
Trial ID
NCT01304498
This phase IV trial investigates whether one dose of a human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones BiomƩdicas (ACIB)
Start Date
2017-11-29
Trial ID
NCT03180034
Background: * Human papilloma virus (HPV) is a common sexually transmitted...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-06-29
Trial ID
NCT00798265
This study is designed to demonstrate non-inferior immunogenicity of 3 dose...
Status
Active Not Recruiting
Location
Liucheng County Centers for Disease Control and Prevention ( Site 0005)
Start Date
2022-05-07
Trial ID
NCT05314023
Treatments Being Tested
The purposes of this phase 3, double-blind, placebo-controlled clinical stu...
Status
Completed
Location
Umeyama Clinic ( Site 6406)
Start Date
2020-11-30
Trial ID
NCT04635423
A phase II random, double blind, positive and placebo control trail was con...
Status
Unknown
Location
Guanyun Country CDC
Start Date
2021-10-19
Trial ID
NCT05060484
Treatments Being Tested